Study of the effect of Lactobacillus crispatus FSCDJY67L3 on Helicobacter Pylori eradication: a double-blind randomized controlled clinical trial
Helicobacter pylori (H. pylori) is a gram-negative bacterium exhibiting high pathogenicity. Traditional antibiotic treatments are considered ineffective as the H. pylori resistance has increased. Recently, a quadruple therapy strategy of probiotics and antibiotics to eliminate H. pylori was proposed...
Main Authors: | Qing Hong, Jidong Wang, Huayue Zhang, Xiaoming Liu, Zhenmin Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1265995/full |
Similar Items
-
Eradication of Helicobacter Pylori in Iran: A Review
by: Hafez Fakheri, et al.
Published: (2018-01-01) -
Role of Helicobacter pylori eradication in the prevention of gastric cancer
by: V V Tsukanov, et al.
Published: (2014-08-01) -
Association between Helicobacter pylori infection, eradication and diabetes mellitus
by: Masayuki Kato, et al.
Published: (2019-09-01) -
Regression of Autoimmune Gastritis after Eradication of Helicobacter pylori
by: Tohru Kotera, et al.
Published: (2023-01-01) -
Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori
by: Yasuhiko Abe, et al.
Published: (2011-07-01)